Home › Funds › BVF INC/IL › IMUX
BVF INC/IL position in IMUX
IMMUNIC INC · Health Care
BVF INC/IL reported holding 765,295 shares of IMUX (IMMUNIC INC) in its Q2 2026 13F filing — a position valued at US$11.8M, representing 0.30% of its reported portfolio and ranking #35 among its reported holdings. BVF INC/IL has disclosed IMUX holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's IMUX position evolved
BVF INC/IL first disclosed a stake in IMUX in Q3 2023 at 1,149,425 shares (US$1.7M). The position peaked in Q3 2024 at 8,902,972 shares, worth US$14.7M. Across 11 filings, BVF INC/IL increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 765,295 shares valued at US$11.8M — a reduction of -6,887,677 shares quarter over quarter.. Notable position changes include a 90% trim in Q2 2026 (shares fell 39% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.15M | $1.69M | New |
| Q1 2024 | 8.90M | $11.75M | New |
| Q2 2024 | 8.90M | $9.88M | Hold |
| Q3 2024 | 8.90M | $14.69M | Hold |
| Q4 2024 | 8.90M | $8.90M | Hold |
| Q1 2025 | 8.90M | $9.70M | Hold |
| Q2 2025 | 7.65M | $5.34M | Reduce |
| Q3 2025 | 7.65M | $6.75M | Hold |
| Q4 2025 | 7.65M | $4.08M | Hold |
| Q1 2026 | 7.65M | $8.49M | Hold |
| Q2 2026 | 765.29K | $11.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMUX and 13F data
IMUX (IMMUNIC INC) is a Health Care company. 37 other funds we track also report a position in IMUX — the largest reported positions include Avidity Partners Management LP (US$10.3M), Laurion Capital Management LP (US$9.4M), Jones Hill Capital LP (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMUX
- Avidity Partners Management LP 669.94K sh · $10.30M · Q2 2026
- Laurion Capital Management LP 610.33K sh · $9.38M · Q2 2026
- Jones Hill Capital LP 539.81K sh · $8.30M · Q2 2026
- Propel Bio Management, LLC 325.02K sh · $5.00M · Q2 2026
More on BVF INC/IL
FAQ
How long has BVF INC/IL held IMUX?
BVF INC/IL has disclosed IMUX holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in IMUX?
As of Q2 2026, BVF INC/IL holds 765.29K shares of IMUX (IMMUNIC INC), valued at $11.76M, representing 0.30% of its reported portfolio and ranking #35.
Has BVF INC/IL been buying or selling IMUX?
In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in IMUX. The position peaked in Q3 2024 at 8.90M shares.
Which other funds hold IMUX?
Other major institutional holders of IMUX include Avidity Partners Management LP, Laurion Capital Management LP, Jones Hill Capital LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.